Gene: C19orf25
Official Full Name: chromosome 19 open reading frame 25provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23480 | C19orf25 Knockout cell line (HeLa) | Human | C19orf25 | 1:3~1:6 | Negative | Online Inquiry |
KO23481 | C19orf25 Knockout cell line (HCT 116) | Human | C19orf25 | 1:2~1:4 | Negative | Online Inquiry |
KO23482 | C19orf25 Knockout cell line (HEK293) | Human | C19orf25 | 1:3~1:6 | Negative | Online Inquiry |
KO23483 | C19orf25 Knockout cell line (A549) | Human | C19orf25 | 1:3~1:4 | Negative | Online Inquiry |
C19orf25 Gene Knockout Cell Lines are specialized cellular models created through targeted genetic engineering techniques to disrupt the C19orf25 gene, which is implicated in a variety of biological processes and diseases. This gene has garnered attention in fields ranging from cancer biology to neurodevelopmental research due to its potential role in cellular proliferation and differentiation. By utilizing CRISPR-Cas9 or similar gene-editing tools, we have effectively rendered these cell lines deficient in the C19orf25 gene functional product, thus allowing researchers to study its contributions to cellular functions and pathways in unprecedented detail.
The key function of the C19orf25 Gene Knockout Cell Lines lies in their ability to facilitate the understanding of gene function by enabling investigation into phenotypic changes arising from the loss of C19orf25 expression. Researchers can utilize these cell lines to discern the impact of C19orf25 on cell survival, migration, and gene expression profiles under various experimental conditions. Such insights can yield valuable information for developing targeted therapies and understanding disease mechanisms at a molecular level.
Scientific importance resides in the potential applications of these cell lines in both research and clinical settings. They can significantly advance areas like cancer research where C19orf25 may be linked to tumor biology, as well as in neuroscience where its roles in neurodevelopment are being unraveled. Furthermore, these knockout models provide a streamlined approach to high-throughput screening of therapeutic compounds aimed at modulating C19orf25-dependent pathways.
What sets our C19orf25 Gene Knockout Cell Lines apart from alternative models is their verified genetic disruptions, characterized by robust phenotypic validation and reproducibility in experimental results. This meticulous validation ensures that researchers can rely on these models for both exploratory research and the development of therapeutic strategies without the concerns of off-target effects that often complicate other gene editing techniques.
For researchers and clinicians, these cell lines represent a cutting-edge tool, offering an efficient means to investigate gene function and therapeutic potential in human biology. Their availability supports innovative research directions in gene therapy and biomarker development, promising to unlock critical insights into various diseases.
At our company, we pride ourselves on our expertise in cellular model development, providing researchers with high-quality biological products that drive scientific discovery and advancement in health care. Our commitment to excellence ensures that customers receive not only advanced tools but also the support needed to realize their research goals effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.